AHPA on USP ingredient information
This article was originally published in The Tan Sheet
Executive SummaryThe American Herbal Products Association asks U.S. Pharmacopoeia to "refrain from requiring cautionary statements" on "USP-quality black cohosh and USP powdered decaffeinated green tea extract" in its newly adopted ingredient safety classification system. Instead, AHPA suggests USP use a safety information section in supplement ingredient monographs to present findings from DSI-EC. This would allow manufacturers "to intelligently apply the findings of the DSI-EC as is appropriate on a product-by-product basis," the group says. The current system adopted by USP classifies ingredients into three categories: Class 1, (safe with no labeling statement), Class 2 (safe with suitable labeling statement) and Class 3 (not safe)...
You may also be interested in...
The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.